- Home
- DNLI vs CNK Comparison
DNLI vs CNK Comparison
Compare DNLI & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | CNK |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DNLI | CNK |
|---|---|---|
| Price | $21.69 | $29.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $34.27 | $33.70 |
| AVG Volume (30 Days) | ★ 1.7M | 1.5M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $3,115,000,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $444.50 | $3.68 |
| P/E Ratio | ★ N/A | $29.24 |
| Revenue Growth | N/A | ★ 2.15 |
| 52 Week Low | $12.31 | $21.60 |
| 52 Week High | $23.77 | $34.01 |
Technical Indicators
Market Signals| Indicator | DNLI | CNK |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 62.02 |
| Support Level | $18.86 | $29.36 |
| Resistance Level | $22.21 | $30.88 |
| Average True Range (ATR) | 1.14 | 0.95 |
| MACD | 0.13 | 0.09 |
| Stochastic Oscillator | 75.42 | 70.73 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.